secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001193125-24-279061
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio prices $30M public offering of 10M shares and warrants
-------------------------------------------------------------

- 10M shares at $3.00/share plus warrants to buy 10M shares at $3.76, 5-year term.
- Gross proceeds $30M; net proceeds ~$27.6M after discounts and expenses.
- Closing expected December 16, 2024, subject to customary conditions.
- Warrants include 4.99% beneficial ownership limitation (up to 9.99% on election).
- Oppenheimer & Co. and Citizens JMP joint book-runners; Stephens Inc. lead manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/0001193125-24-279061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/d899983d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-279061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer